Vice-president of research and development (R&D) Dr Trevor Calkins discusses Pfanstiehl’s active pharmaceutical ingredients (API) contract development and manufacturing organisation (CDMO) philosophy and capabilities at the CPhI/InformEx exhibition in Philadelphia.
Pfanstiehl offers a wide array of API development services at its campus just north of Chicago.
The company has one of the first Safebridge-certified facilities in the world and is passionate about solving complex chemistry challenges.
The company is focused on being in lockstep with clients from early preclinical through commercialisation.
Pfanstiehl
Subscribed
You have successfully submitted your enquiry. Someone from our company will respond ASAP
Pfanstiehl Tradeshow Video
